INDICATION AND IMPORTANT SAFETY INFORMATION
TOBI® Podhaler® (Tobramycin Inhalation Powder) 28 mg per capsule is indicated for the management of cystic fibrosis patients with Pseudomonas aeruginosa. ...More
A centralized support and access program for TOBI® Podhaler® patients
Learn moreSET TREATMENT EXPECTATIONS
Inform your patients about what to expect while taking TOBI® Podhaler®
Learn moreADMINISTRATION INFORMATION
Administration information and helpful tips for patients taking TOBI® Podhaler®
Learn more